Observational studyBMC urology2017

Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia.

Antoni Sicras-Mainar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.